Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
Advisor, aforementioned, Alexion, alia, ancillary, bifurcated, burden, Choi, circumvention, Cocrystal, collateral, conversion, correct, Counterclaim, customer, deficiency, degradation, denying, discrepancy, dominant, drafting, dual, earliest, EASL, Enanta, encapsidation, enjoin, ETV, exacerbate, Fargo, frame, front, GalNAc, Gastroenterology, glycolate, greatest, HBx, immaterial, impracticable, inflow, infrastructure, injunction, injunctive, Intellia, inter, Interbank, interdependent, intraday, kind, lender, LIBOR, MAA, manipulation, margin, mathematical, Modulator, outlook, overriding, overstatement, PegIFN, Perelman, pgRNA, poster, predominant, premium, presidential, procedure, purporting, rcDNA, reform, relief, renovate, repaid, repay, repeal, repealed, smaller, software, sophisticated, spreadsheet, steady, Sterilizer, supervision, Supplementary, Supreme, synergistic, titled, Topline, transition, Triple, Trump, uncoating, undelivered, understatement, unexercised, urged, urine, vitro, vivo, Warminster, withholding, wrongly
Removed:
AG, AlCana, Amyloidotic, awaiting, biomedical, body, bringing, choose, closed, conference, convert, dealing, declaration, demanded, determinable, discovered, element, emergency, employ, encapsulated, encouraging, filer, forfeiture, Germany, Hangzhou, Herrington, hiring, hosted, identifying, improving, initiate, irregular, Kowalski, labelling, LLP, manager, moved, moving, nil, North, payload, Polyneuropathy, prescribe, presenting, produced, provisional, reach, reaction, realizable, realize, relationship, safeguarded, San, submitted, Sutcliffe, systemic, translate, underwriter, USA, wide, workforce
Filing tables
Filing exhibits
- 10-K Annual report
- 10.62 Ex 10.62 Dod Termination
- 10.63 Exhibit 10.63 Neurovive Termination
- 10.64 Ex 10.64 Dicerna Termination
- 10.65 Ex 10.65 Cytos Termination
- 10.66 Ex 10.66 Bill Symonds Employ Amemd
- 10.67 Ex 10.67 Alexion License Agreement
- 21.1 Exhibit 21.1
- 23.1 Exhibit 23.1
- 31.1 Exhibit 31.1 10K CEO
- 31.2 Exhibit 31.2 10-K CFO
- 32.1 Exhibit 32.1 CEO Sox
- 32.2 Exhibit 32.2 CFO Sox
- Download Excel data file
- View Excel data file
Related press release
ABUS similar filings
Filing view
External links
Exhibit 10.64
November 20, 2016
Douglas M. Fambrough, III Ph.D.
Chief Executive Officer
Dicerna Pharmaceuticals Inc.
87 Cambridgepark Drive
Cambridge, MA 02140
Dear Doug,
I am writing you regarding the License Agreement by and between Dicerna Pharmaceuticals, Inc. (“Dicerna”), on the one hand, and Protiva Biotherapeutics Inc. and Tekmira Pharmaceuticals Corporation (predecessor in interest of Arbutus Biopharma Corporation or “Arbutus”) on the other hand, dated November 16, 2014 (“Agreement”).
By agreement of the parties, the Agreement is now terminated, effective November 21, 2016. Pursuant to section 8.6 (b) of the Agreement, the Supply Agreement and Quality Agreement between Dicerna and Arbutus also automatically terminates, with the proviso that within thirty (30) days after termination of the Agreement (namely December 20, 2016), Dicerna will provide Arbutus with an inventory of all Products in its, its Affiliates’ and their Sublicensees’ (including CMO’s) possession or control, including finished products and works-in-process.
Yours truly,
/s/ Thomas Frohlich